SFTPA2 and retinopathy of prematurity: As no previous reports have assessed surfactant protein polymorphisms in either ROP or human eye disease, we designed this study to interrogate the hypothesis that the SFTPA1/ SFTPA2 haplotype 6A2/1A0 decreases the risk of severe ROP (Stage III or greater/Zone II or less) or ROP requiring treatment.